BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28244413)

  • 1. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
    Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Consent for Clinical Trials in Cardiovascular Disease.
    Kerkhoff LA; Butler J; Kelkar AA; Shore S; Speight CD; Wall LK; Dickert NW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
    Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
    Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drivers and barriers to patient participation in RCTs.
    Jenkins V; Farewell V; Farewell D; Darmanin J; Wagstaff J; Langridge C; Fallowfield L;
    Br J Cancer; 2013 Apr; 108(7):1402-7. PubMed ID: 23511558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motivation and barriers to participation in clinical trials].
    Gaul C; Schmidt T; Helm J; Hoyer H; Haerting J
    Med Klin (Munich); 2006 Nov; 101(11):873-9. PubMed ID: 17235473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing an alternate informed consent process.
    Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
    Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing clinical trial enrollment among ovarian cancer patients.
    Greenwade MM; Moore KN; Gillen JM; Ding K; Rowland MR; Crim AK; Kleis B; Gunderson CC
    Gynecol Oncol; 2017 Sep; 146(3):465-469. PubMed ID: 28689668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study.
    Ivie RM; Vail EA; Wunsch H; Goldklang MP; Fowler R; Moitra VK
    Crit Care Med; 2017 Feb; 45(2):216-224. PubMed ID: 27779514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.
    Garrett SB; Matthews TM; Abramson CM; Koenig CJ; Hlubocky FJ; Daugherty CK; Munster PN; Dohan D
    JCO Oncol Pract; 2020 Jan; 16(1):e56-e63. PubMed ID: 31603726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
    Nipp RD; Lee H; Powell E; Birrer NE; Poles E; Finkelstein D; Winkfield K; Percac-Lima S; Chabner B; Moy B
    Oncologist; 2016 Apr; 21(4):467-74. PubMed ID: 26975867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Advanced Non-Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
    Lim C; Sung M; Shepherd FA; Nouriany N; Sawczak M; Paul T; Perera-Low N; Foster A; Zawisza D; Feld R; Liu G; Leighl NB
    J Thorac Oncol; 2016 Jan; 11(1):79-84. PubMed ID: 26762742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
    Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.
    Humphreys K; Maisel NC; Blodgett JC; Finney JW
    J Stud Alcohol Drugs; 2013 Nov; 74(6):889-93. PubMed ID: 24172115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of reasons for non-enrollment in a phase III randomized controlled trial.
    Murthy V; Awatagiri KR; Tike PK; Ghosh-Laskar S; Gupta T; Budrukkar A; Deshpande MS; Chaukar DA; Pantavaidya GH; Agarwal JP
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S94-9. PubMed ID: 22322738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.